This transaction was conducted on November 29, 2024, and was required to cover tax withholding obligations related to the issuance of shares, as noted in the filing. InvestingPro data shows the company maintains strong financial health with liquid assets exceeding short-term obligations and moderate debt levels. Following this transaction, Pawar holds 1,165,345 shares of Enfusion. Subscribers to InvestingPro can access 10+ additional key insights about Enfusion's financial health and valuation metrics.
This transaction was conducted on November 29, 2024, and was required to cover tax withholding obligations related to the issuance of shares, as noted in the filing. InvestingPro data shows the company maintains strong financial health with liquid assets exceeding short-term obligations and moderate debt levels. Following this transaction, Pawar holds 1,165,345 shares of Enfusion. Subscribers to InvestingPro can access 10+ additional key insights about Enfusion's financial health and valuation metrics.
In other recent news, Enfusion Inc. has reported a successful third quarter in 2024, with a significant 15% increase in year-over-year revenue to $51.2 million and an adjusted EBITDA of $11.1 million, which represents a 21.8% margin. The company's annual recurring revenue surpassed $200 million, marking a 14% year-over-year increase. Enfusion has also attracted 38 new clients, bringing the total to 894.
The company's revenue growth was observed across all regions, with the Americas reporting a 17% increase, EMEA 22%, and Asia-Pacific 6%. Enfusion is revising its full-year revenue guidance to between $202 million and $205 million, with EBITDA guidance at $41 million to $45 million.
These recent developments indicate Enfusion's strategic focus on product innovation and market expansion, which has led to a substantial increase in new client acquisitions. The management team expressed confidence in the company's positioning for future growth through product innovation, strategic partnerships, and improved forecasting processes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.